|
glucagon, trace elements, tropical animal production, body fat analyzer, heat wrap, bjc, livestock production, milk quality, metabolism, inkjet toner, body composition, fat substitute, konica, bodyfat scales, fattrack gold, olivetti, pentabosol,
|
At baseline, there was no difference between the groups for either weight, BMI, body fat mass or lean body mass. After only six months of observation, individuals taking either form of CLA experienced a significant reduction in body fat mass, while those in the placebo group saw no change. Daily caloric intake and exercise was not different between groups either at zero or 12 months and thus most likely did not healthcare news play a role in body composition changes observed healthcare news in the CLA groups. Both forms of CLA were equally efficacious in body fat mass reduction and proven healthcare news safe, when used for one year in healthy, yet overweight, adults. Study related adverse events, typically rated as "mild" or "moderate" in nature, were nearly equal among groups taking either CLA or placebo (3-5 percent). The most common side effect was gastrointestinal complaints. The CLA used in this study was TONALIN(R) CLA, an exclusive product of the Cognis Group. TONALIN(R), the number one consumer brand of CLA, is intended to help consumers lose body fat, maintain lean body mass, prevent fat regain and contribute to improved overall health.
|
